Related Experiment Video
Updated: Jun 14, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Endoscopic hemostasis with fibrin glue for refractory postsphincterotomy and postpapillectomy bleeding
M Mutignani1, T Seerden, A Tringali
1Digestive Endoscopy Unit, Department of Surgery, Sacro Cuore Catholic University, Rome, Italy. massimiliano.mutignani@rm.unicatt.it
Background:
Bleeding is a feared complication of endoscopic sphincterotomy and papillectomy. Fibrin glue has been proposed as an effective adjunct in securing hemostasis. However, its use has been limited by the risk of early occlusion of the injecting needle, and its role has not been defined in the setting of refractory post-ERCP bleeding. We present a modified technique of endoscopic hemostasis with diluted fibrin glue in the setting of postsphincterotomy and postpapillectomy bleeds.
Objective:
We aimed to verify that diluted fibrin glue can be easily and successfully injected and is effective in the endoscopic treatment of refractory post-ERCP bleeding.
Design:
Case series.
Setting:
A tertiary-care academic medical center.
Patients:
Six patients with refractory post-ERCP bleeding were treated (3 after sphincterotomy and 3 after papillectomy) with fibrin glue injection.
Intervention:
Endoscopic hemostasis with diluted fibrin glue injection.
Main Outcome Measurements:
Successful endoscopic hemostasis with diluted fibrin glue injection.
Results:
One session of fibrin glue injection stopped the refractory post-ERCP bleeding in all 6 patients.
Limitation:
Small number of patients.
Conclusion:
This case series provides evidence that our modified injection technique of diluted fibrin glue allowed an easy submucosal injection and may be considered to be an effective endoscopic modality to treat refractory post-ERCP bleeding.
Related Concept Videos
Clot Retraction and Fibrinolysis
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
